Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
Australia's cervical screening program transitioned from cytology to HPV-testing with genotyping for HPV16/18 in Dec’2017. We investigated whether program data could be used to monitor HPV vaccination program impact (commenced in 2007) on HPV16/18 prevalence and compared estimates with pre-vacc...
Main Authors: | Louiza S. Velentzis, David Hawkes, Michael Caruana, Julia ML. Brotherton, Megan A. Smith, Lara Roeske, Khurram A. Karim, Suzanne M. Garland, C. David Wrede, Jeffery Tan, Cosette Wheeler, Philip E. Castle, Marion Saville, Karen Canfell |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Tumour Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666679023000022 |
Similar Items
-
Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens
by: Isabella W. Martin, et al.
Published: (2012-09-01) -
Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
by: Xushan Cai, et al.
Published: (2019-08-01) -
Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
by: Dan Jang, et al.
Published: (2021-12-01) -
Cobas® 4800 HPV test is accurate for detecting high risk Human Papillomavirus from urine samples at dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia
by: Indiarto Wityawan, et al.
Published: (2022-12-01) -
A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination
by: Louiza S Velentzis, et al.
Published: (2023-10-01)